{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443998859
| IUPAC_name = (9''R'',10''R'')-10-(acetyloxy)-8,8-dimethyl-2-oxo-9,10-dihydro-2''H'',8''H''-pyrano[2,3-''f'']chromen-9-yl (2''R'')-2-methylbutanoate
| image = Visnadine.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|visnadine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 477-32-7
| ATC_prefix = C04
| ATC_suffix = AX24
| PubChem           = 442151
| ChemSpiderID      = 390669
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0RL4V0K263
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08735

<!--Chemical data-->
| C=21 | H=24 | O=7 
| molecular_weight = 388.41 g/mol
| smiles            = CC[C@H](C(=O)O[C@H]1[C@@](OC2=C([C@H]1OC(=O)C)C3=C(C=CC(=O)O3)C=C2)(C)C)C
| StdInChI          = 1S/C21H24O7/c1-6-11(2)20(24)27-19-18(25-12(3)22)16-14(28-21(19,4)5)9-7-13-8-10-15(23)26-17(13)16/h7-11,18-19H,6H2,1-5H3/t11-,18-,19-/m1/s1
| StdInChIKey       = GVBNSPFBYXGREE-CXWAGAITSA-N
}}

'''Visnadine''' (or '''visnadin''') is a natural [[vasodilator]].<ref>{{cite journal|last=Durate|first=J|author2=Vallejo I |author3=Pérez-Vizcaino F |author4=Jiménez R |author5=Zarzuelo A |author6=Tamargo J |date=1997|title=Effects of visnadine on rat isolated vascular smooth muscles.     .|journal=Planta Med|publisher=Thieme Medical Publishers|volume=63|issue=3|pages=233–6|issn=1439-0221|url=http://www.thieme-connect.de/ejournals/abstract/plantamedica/doi/10.1055/s-2006-957660|doi=10.1055/s-2006-957660|pmid=9225605}}</ref>  It was first isolated from [[Ammi visnaga|bishop's weed]] (''Ammi visnaga''), a plant indigenous to the Mediterranean region which has been used for centuries in Egypt as a spasmolytic.<ref>{{cite journal | title = Constitution of Samidin, Dihydrosamidin and Visnadin |author1=Eric Smith |author2=Norman Hosansky |author3=W. G. Bywater |author4=Eugene E. van Tamelen  |last-author-amp=yes | journal = J. Am. Chem. Soc. | year = 1957 | volume = 79 | issue = 13 | pages = 3534–3540 | doi = 10.1021/ja01570a062}}</ref>

==References==
{{reflist}}

{{Peripheral vasodilators}}

[[Category:Lactones]]
[[Category:Vasodilators]]
[[Category:Pyranochromenes]]
[[Category:Acetate esters]]


{{cardiovascular-drug-stub}}